Stryker (SYK) Enterprise Value Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.48% |
| Dec 31, 2025 | -6.28% |
| Sep 30, 2025 | 14.13% |
| Jun 30, 2025 | 18.53% |
| Mar 31, 2025 | 10.54% |
| Dec 31, 2024 | 0.10% |
| Sep 30, 2024 | -14.08% |
| Jun 30, 2024 | -1.25% |
| Mar 31, 2024 | -6.49% |
| Dec 31, 2023 | 3.77% |
| Sep 30, 2023 | 2.61% |
| Jun 30, 2023 | 5.10% |
| Mar 31, 2023 | 6.40% |
| Dec 31, 2022 | 7.05% |
| Sep 30, 2022 | 11.05% |
| Jun 30, 2022 | 21.36% |
| Mar 31, 2022 | 14.14% |
| Dec 31, 2021 | 2.26% |
| Sep 30, 2021 | 2.67% |
| Jun 30, 2021 | 8.66% |
| Mar 31, 2021 | 20.94% |
| Dec 31, 2020 | 5.81% |
| Sep 30, 2020 | -16.26% |
| Jun 30, 2020 | -9.13% |
| Mar 31, 2020 | 1.03% |
| Dec 31, 2019 | 2.41% |
| Sep 30, 2019 | 15.32% |
| Jun 30, 2019 | 17.27% |
| Mar 31, 2019 | 15.36% |
| Dec 31, 2018 | 1.45% |
| Sep 30, 2018 | 15.53% |
| Jun 30, 2018 | 16.22% |
| Mar 31, 2018 | 11.43% |
| Dec 31, 2017 | 8.30% |
| Sep 30, 2017 | 6.99% |
| Jun 30, 2017 | -1.61% |
| Mar 31, 2017 | 0.11% |
| Dec 31, 2016 | 0.20% |
| Sep 30, 2016 | 1.22% |
| Jun 30, 2016 | -48.43% |
| Mar 31, 2016 | -20.99% |
| Dec 31, 2015 | 1.41% |
| Sep 30, 2015 | -4.88% |
| Jun 30, 2015 | -1.20% |
| Mar 31, 2015 | -1.60% |
| Dec 31, 2014 | -11.09% |
| Sep 30, 2014 | -9.81% |
| Jun 30, 2014 | -14.34% |